Fondaparinux Subcutaneous and Vitrakvi (Larotrectinib Capsules)
Determining the interaction of Fondaparinux Subcutaneous and Vitrakvi (Larotrectinib Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fondaparinux
Brand name: Arixtra, Arixtra 5 mg/dose, Arixtra 75 mg/dose, Arixtra 10 mg/dose
Synonyms: Fondaparinux
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Vitrakvi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fondaparinux Subcutaneous-Vitrakvi (Larotrectinib Oral Solution)
- Fondaparinux Subcutaneous-Vitrase
- Fondaparinux Subcutaneous-Vitrase injection
- Fondaparinux Subcutaneous-Vitravene
- Fondaparinux Subcutaneous-Vitron-C
- Fondaparinux Subcutaneous-Vituz
- Vitrakvi (Larotrectinib Capsules)-Foradil
- Vitrakvi (Larotrectinib Capsules)-Foradil Aerolizer
- Vitrakvi (Larotrectinib Capsules)-Forane
- Vitrakvi (Larotrectinib Capsules)-Forfivo XL
- Vitrakvi (Larotrectinib Capsules)-Formerly available as Dalmane
- Vitrakvi (Larotrectinib Capsules)-Formerly available as Librium